Chefaa
PrivateLast Round
Series A
Dec 17, 2023
Est. Valuation
$280,000
Total Funding Raised
$6.28M
Company Overview
Chefaa operates in Healthcare & Life Sciences and is based in Cairo. Its latest recorded funding round was a Series A round in December 2023.
Chefaa is a health-tech company that provides an AI-powered, patient-centric platform for ordering, scheduling, and refilling prescriptions from a network of pharmacies.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Patient Engagement, Pharma Supply Chain, Telemedicine
Business Model
B2C
Customer Profile
Marketplace Commission, Data as a Service, Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chefaa Comparables
Compare Chefaa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yodawy | 88% | |
| BelShifa | 87% | |
| Dawaya | 72% |
For institutional investors. Book with your work email.
Chefaa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 17, 2023 | ||||
| VC Round | Mar 6, 2022 | ||||
| Early Funding | Jun 14, 2020 | ||||
| Seed | Aug 13, 2019 | ||||
| Pre Seed | May 14, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Chefaa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Womena | Early Funding |
| GMS Capital | Series A, VC Round |
| Newtown Partners | VC Round, Series A |
| Flat6Labs | Seed, Grant, Pre Seed |
| 500 Global | Seed, Early Funding |
| Global Brain Corporation | VC Round, Series A |
| Vision Ventures | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Open roles increased from 0 to 65, representing 48% of headcount.
- Mar 6, 2022
Raised $2.5M from Global Brain Corporation and Newtown Partners.
For institutional investors. Book with your work email.
Chefaa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chefaa's valuation, stock price, and market status.
Is Chefaa a public or private company?
Chefaa is a private company.
What is the current stock price of Chefaa?
Chefaa is a private company, so its shares have no public market price. Caplight tracks Chefaa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chefaa worth (valuation)?
Chefaa's valuation is estimated at $280.0K based on funding round data.
Can I buy Chefaa stock?
Chefaa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chefaa's last funding round?
Chefaa's most recent funding round was Series A on December 17, 2023.
Who are the main investors in Chefaa?
Key investors in Chefaa include Newtown Partners, Flat6Labs, 500 Global, Global Brain Corporation.
Will Chefaa IPO soon?
No public IPO plans have been announced for Chefaa.
How can I track Chefaa secondary market activity?
Caplight tracks bids, offers, and trades in Chefaa's shares on secondary markets.